Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome

Eur Child Adolesc Psychiatry. 2008 Mar;17(2):73-81. doi: 10.1007/s00787-007-0638-8. Epub 2007 Sep 14.

Abstract

Objective: The present study investigated the predictive power of anxiety, IQ, severity of ADHD and parental depression on the outcome of treatment in children with ADHD.

Method: Fifty children with ADHD (ages 8-12) were randomized to a 10-week treatment of methylphenidate or to a treatment of methylphenidate combined with multimodal behavior therapy. Prior to treatment predictors were assessed. Outcome was assessed separately for parents and teachers on a composite measure of inattentive, hyperactive, oppositional- and conduct disorder symptoms.

Results: There was neither a significant difference between the two treatments at baseline nor did treatment condition predict outcome. Therefore the data were collapsed across the two treatments. A combination of anxiety and IQ predicted teacher-rated outcome, explaining 18% of the variance. Higher anxiety and higher IQ's indicated better treatment outcome. There were no significant predictors of the parent-rated outcome.

Conclusion: This study showed a small but significant predictive effect of IQ and anxiety on treatment outcome in children with ADHD.

Clinical implications: This study supports the idea that for the treatment of ADHD children with comorbid anxiety and higher IQ respond better to the two most used treatments for ADHD.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Attention Deficit Disorder with Hyperactivity / diagnosis*
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / psychology
  • Behavior Therapy*
  • Central Nervous System Stimulants / therapeutic use*
  • Child
  • Female
  • Humans
  • Male
  • Methylphenidate / therapeutic use*
  • Predictive Value of Tests
  • Prospective Studies
  • Treatment Outcome

Substances

  • Central Nervous System Stimulants
  • Methylphenidate